Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04112381 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bilateral Treatment of Medication Refractory Essential Tremor

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 1, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Mar 2023 to Mar 2026 Completion date: Jun 2023 to Jun 2026v14 Show 1 more changeShow less
    • Completion date: Jun 2023 to Jun 2026
  2. Primary completion date: Mar 2022 to Mar 2023 Completion date: Mar 2026 to Jun 2023v13 Show 1 more changeShow less
    • Completion date: Mar 2026 to Jun 2023
  3. Re-verified, no change to tracked fieldsv12
  4. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 50 to confirmed 51 · Site details revised at 7 of 7 sitesv11 Show 2 more changesShow less
    • Enrollment target: estimated 50 to confirmed 51
    • Site details revised at 7 of 7 sites
  5. Study sites: 6 to 7v10
Show 8 earlier versionsHide 8 earlier versions
  1. Study sites: 4 to 6v9
  2. Enrollment target: 20 to 50 Start date changed from estimate of Jul 2020 to Jun 30, 2020v8 Show 1 more changeShow less
    • Start date changed from estimate of Jul 2020 to Jun 30, 2020
  3. Study sites: 3 to 4v7
  4. Start date: Jun 2020 to Jul 2020v6
  5. Study sites: 2 to 3v5
  6. Primary completion date: Jun 2021 to Mar 2022 Study sites: 1 to 2 · Completion date: Jun 2027 to Mar 2026 · Start date: May 2020 to Jun 2020v4 Show 3 more changesShow less
    • Study sites: 1 to 2
    • Completion date: Jun 2027 to Mar 2026
    • Start date: May 2020 to Jun 2020
  7. Start date: Mar 2020 to May 2020v3
  8. Trial status: Not Yet Recruiting to Recruiting Enrollment target: 10 to 20v2 Show 1 more changeShow less
    • Enrollment target: 10 to 20
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
InSightec
42 trials monitored
See 1 trial at risk
The purpose of this study is to see if the MR-guided focused ultrasound (MRgFUS) thalamotomy procedure can be performed on both sides of the brain safely and effectively to reduce bilateral tremor.
Trial Details
NCT Number NCT04112381
Lead Sponsor InSightec
Conditions Essential Tremor
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov